#daraxonrasib — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #daraxonrasib, aggregated by home.social.
-
https://www.europesays.com/ie/707524/ FDA approves new pill for pancreatic cancer treatment #daraxonrasib #Éire #Health #IE #Ireland #JonathanMizrahi #JonelleBershad #Ochsner #OchsnerHealth #OchsnerMDAndersonCancerCenter #PancreaticCancer #PancreaticCancerPill #rasonque
-
https://www.europesays.com/cz/224223/ Naděje pro pacienty s rakovinou slinivky. Nový lék míří do Evropy #ČeskáRepublika #chemoterapie #Daraxonrasib #Headlines #HlavníUdálosti #Léčba #Metastázy #News #Rakovina #RakovinaSlinivkyBřišní #Slinivka #StátníústavProKontroluLéčiv(SÚKL) #TopNews #TopStories #UdálostiDne #USA #Zprávy
-
Ein neuer #Bluttest könnte künftig die #Früherkennung von #Bauchspeicheldrüsenkrebs bei Menschen mit erhöhtem Risiko unterstützen.
Er kombiniert drei Biomarker zu einem Risikowert. Bis zum möglichen Einsatz sind wegen noch bestehender Unsicherheiten weitere Untersuchungen nötig. Parallel eröffnet der RAS-Inhibitor #Daraxonrasib neue Behandlungsoptionen bei metastasierten Tumoren. Die Zulassung in Europa ist beantragt.
https://www.tagesschau.de/wissen/gesundheit/bluttest-bauspeicheldruesenkrebs-100.html
-
Ein neuer #Bluttest könnte künftig die #Früherkennung von #Bauchspeicheldrüsenkrebs bei Menschen mit erhöhtem Risiko unterstützen.
Er kombiniert drei Biomarker zu einem Risikowert. Bis zum möglichen Einsatz sind wegen noch bestehender Unsicherheiten weitere Untersuchungen nötig. Parallel eröffnet der RAS-Inhibitor #Daraxonrasib neue Behandlungsoptionen bei metastasierten Tumoren. Die Zulassung in Europa ist beantragt.
https://www.tagesschau.de/wissen/gesundheit/bluttest-bauspeicheldruesenkrebs-100.html
-
Ein neuer #Bluttest könnte künftig die #Früherkennung von #Bauchspeicheldrüsenkrebs bei Menschen mit erhöhtem Risiko unterstützen.
Er kombiniert drei Biomarker zu einem Risikowert. Bis zum möglichen Einsatz sind wegen noch bestehender Unsicherheiten weitere Untersuchungen nötig. Parallel eröffnet der RAS-Inhibitor #Daraxonrasib neue Behandlungsoptionen bei metastasierten Tumoren. Die Zulassung in Europa ist beantragt.
https://www.tagesschau.de/wissen/gesundheit/bluttest-bauspeicheldruesenkrebs-100.html
-
Ein neuer #Bluttest könnte künftig die #Früherkennung von #Bauchspeicheldrüsenkrebs bei Menschen mit erhöhtem Risiko unterstützen.
Er kombiniert drei Biomarker zu einem Risikowert. Bis zum möglichen Einsatz sind wegen noch bestehender Unsicherheiten weitere Untersuchungen nötig. Parallel eröffnet der RAS-Inhibitor #Daraxonrasib neue Behandlungsoptionen bei metastasierten Tumoren. Die Zulassung in Europa ist beantragt.
https://www.tagesschau.de/wissen/gesundheit/bluttest-bauspeicheldruesenkrebs-100.html
-
https://www.europesays.com/it/675079/ “Mia madre ha un tumore al pancreas in fase metastatica. Caro presidente Mattarella, aiuti le famiglie a sbloccare il farmaco daraxonrasib” #aiuti #daraxonrasib #famiglie #farmaco #fase #Health #IT #Italia #Italy #madre #mattarella #metastatica #pancreas #presidente #Salute #sbloccare #tumore
-
https://www.europesays.com/ie/670945/ FDA Approves Rasonque for Metastatic Pancreatic Cancer After Study Shows Longer Survival | Ukraine news #daraxonrasib #Éire #FDAApproval #Health #IE #Ireland #Medication #MetastaticPancreaticCancer #News #PancreaticCancerTreatment #rasonque #RasonqueDaraxonrasibMetastaticPancreaticCancerFdaApprovalPancreaticCancerTreatmentRevolutionMedicines #RevolutionMedicines
-
https://www.europesays.com/it/660471/ Tumore al pancreas, una nuova pillola quasi raddoppia la sopravvivenza #AdenocarcinomaPancreaticoMetastatico #AmericanCancerSociety #daraxonrasib #FDA #Health #IT #Italia #Italy #NationalCancerInstitute(NCI) #NewEnglandJournalOfMedicine #O’ReillyEM #RASolute302 #Salute #StatiUniti #UnioneEuropea
-
https://www.europesays.com/ie/666989/ St. Johnsbury woman finds hope in new pancreatic cancer drug after losing husband #cancer #daraxonrasib #Drug #Éire #fda #Health #IE #Ireland #Medication #pancreatic #RevolutionMedicines #UVMMedicalCenter #vermont #WCAX
-
https://www.europesays.com/it/657805/ Tumore al pancreas, la prima terapia orale con il Daraxonrasib: “La nuova pillola funziona meglio della chemioterapia” #chemioterapia #daraxonrasib #funziona #Health #IT #Italia #Italy #nuova #orale #pancreas #pillola #Salute #terapia #tumore
-
Newly approved drug is a "game changer" for Stage 4 pancreatic cancer patients – Central Oregon Daily
Newly approved drug is a “game changer” for Stage 4 pancreatic cancer patients Central Oregon DailyFDA Approves Drug for…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #cancer #Daraxonrasib #Health #pancreatic #Therapy #Treatment
https://www.newsbeep.com/us/828216/ -
Newly approved drug is a "game changer" for Stage 4 pancreatic cancer patients – Central Oregon Daily
Newly approved drug is a “game changer” for Stage 4 pancreatic cancer patients Central Oregon DailyFDA Approves Drug for…
#NewsBeep #News #Medication #AU #Australia #Cancer #daraxonrasib #Health #pancreatic #therapy #treatment
https://www.newsbeep.com/au/870936/ -
https://www.europesays.com/ie/660093/ Newly approved drug is a "game changer" for Stage 4 pancreatic cancer patients – Central Oregon Daily #cancer #daraxonrasib #Éire #Health #IE #Ireland #Medication #pancreatic #therapy #treatment
-
https://www.europesays.com/uk/1173173/ Newly approved drug is a "game changer" for Stage 4 pancreatic cancer patients – Central Oregon Daily #Cancer #daraxonrasib #Health #Medication #pancreatic #Therapy #treatment #UK #UnitedKingdom
-
FDA approves pancreatic cancer drug that extends patients’ lives
The Food and Drug Administration has approved a new pancreatic cancer drug,
a pill that nearly doubled patients’ average survival times
for one of the deadliest cancers
when taken instead of chemotherapy.
Researchers have called the drug,
known as #Rasonque or #daraxonrasib and taken daily,
a “landmark” development.It has been one of the most closely watched experimental cancer treatments.
In a trial of 500 adults with metastatic pancreatic cancer
who had been previously treated for the condition,
patients who took daraxonrasib had a median survival period of about
13.2 months, compared with
6.7 months for those who received chemotherapy.
When the trial results were presented at an American Society of Clinical Oncology meeting earlier this year,
the room erupted in applause and a standing ovation. Some in the audience were in tears -
FDA approves pancreatic cancer drug that extends patients’ lives
The Food and Drug Administration has approved a new pancreatic cancer drug,
a pill that nearly doubled patients’ average survival times
for one of the deadliest cancers
when taken instead of chemotherapy.
Researchers have called the drug,
known as #Rasonque or #daraxonrasib and taken daily,
a “landmark” development.It has been one of the most closely watched experimental cancer treatments.
In a trial of 500 adults with metastatic pancreatic cancer
who had been previously treated for the condition,
patients who took daraxonrasib had a median survival period of about
13.2 months, compared with
6.7 months for those who received chemotherapy.
When the trial results were presented at an American Society of Clinical Oncology meeting earlier this year,
the room erupted in applause and a standing ovation. Some in the audience were in tears -
FDA approves pancreatic cancer drug that extends patients’ lives
The Food and Drug Administration has approved a new pancreatic cancer drug,
a pill that nearly doubled patients’ average survival times
for one of the deadliest cancers
when taken instead of chemotherapy.
Researchers have called the drug,
known as #Rasonque or #daraxonrasib and taken daily,
a “landmark” development.It has been one of the most closely watched experimental cancer treatments.
In a trial of 500 adults with metastatic pancreatic cancer
who had been previously treated for the condition,
patients who took daraxonrasib had a median survival period of about
13.2 months, compared with
6.7 months for those who received chemotherapy.
When the trial results were presented at an American Society of Clinical Oncology meeting earlier this year,
the room erupted in applause and a standing ovation. Some in the audience were in tears -
FDA approves pancreatic cancer drug that extends patients’ lives
The Food and Drug Administration has approved a new pancreatic cancer drug,
a pill that nearly doubled patients’ average survival times
for one of the deadliest cancers
when taken instead of chemotherapy.
Researchers have called the drug,
known as #Rasonque or #daraxonrasib and taken daily,
a “landmark” development.It has been one of the most closely watched experimental cancer treatments.
In a trial of 500 adults with metastatic pancreatic cancer
who had been previously treated for the condition,
patients who took daraxonrasib had a median survival period of about
13.2 months, compared with
6.7 months for those who received chemotherapy.
When the trial results were presented at an American Society of Clinical Oncology meeting earlier this year,
the room erupted in applause and a standing ovation. Some in the audience were in tears -
https://www.europesays.com/it/650885/ Tumore del pancreas, la FDA rompe il muro di RAS #AdenocarcinomaPancreaticoMetastatico #daraxonrasib #FDAAutorizzazione #Health #InibitoriRAS #IT #Italia #Italy #kras #Salute #SopravvivenzaGlobale #TerapiaMirata #TrialFase3RASolute302
-
https://www.europesays.com/es/732399/ EEUU aprueba una pastilla revolucionaria contra el cáncer de páncreas: «Es un avance enorme» #CáncerDePáncreas #daraxonrasib #eeuu #ES #España #FDA #Health #Rasonque #Salud #Spain
-
https://www.europesays.com/at/330789/ Panregza im Fokus: neuer Bluttest erkennt frühe Stadien beim Pankreaskrebs #AI #ARTIFICIALINTELLIGENCE #AT #Austria #BifidobacteriumLongum #Bluttest #Ca199 #Daraxonrasib #Eclia #Früherkennung #GenPanel #Gesundheit #Health #Immuntherapie #KI #KünstlicheIntelligenz #Österreich #Pankreaskarzinom #Pankreaskrebs #Probiotikum #Sensitivität #Spezifität #TZellen
-
https://www.europesays.com/at/326331/ Experimentelles Medikament daraxonrasib startet in Illinois: Hoffnung bei metastasiertem Bauchspeicheldrüsenkrebs #AI #ARTIFICIALINTELLIGENCE #AT #Austria #Bauchspeicheldrüsenkrebs #Daraxonrasib #ExpandedAccess #FDA #Gesundheit #Health #KI #KlinischeStudie #KünstlicheIntelligenz #Metastasiert #Onkologie #Österreich #RevolutionMedicines #ZielgerichteteTherapie
-
Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic Cancer
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasda…
#NewsBeep #News #Medication #AU #Australia #cytotoxicchemotherapy #daraxonrasib #enrolledpatients #FDA #FDACommissioner #Health #Inc #PancreaticCancer #RevolutionMedicines #U.S.FoodandDrugAdministration
https://www.newsbeep.com/au/820022/ -
https://www.europesays.com/ie/601389/ Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic Cancer #CytotoxicChemotherapy #daraxonrasib #Éire #EnrolledPatients #fda #FDACommissioner #Health #IE #Inc #Ireland #Medication #PancreaticCancer #RevolutionMedicines #USFoodAndDrugAdministration
-
https://www.europesays.com/it/581505/ Tumore al pancreas, la pillola che frena il motore della malattia #CarcinomaPancreaticoMetastatico #chemioterapia #ControlloDellaMalattia #daraxonrasib #Health #IT #Italia #Italy #kras #RASolute302 #RevolutionMedicines #Salute #SopravvivenzaGlobale #TerapieMirate #tollerabilità
-
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Daraxonrasib #ema #FDA #Health #Inc. #NationalPriorityVoucher #pancreaticcancer #patients #Pilotprogram #RASmutations #RevolutionMedicines
https://www.newsbeep.com/us/750531/ -
https://www.europesays.com/ie/575127/ European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process ##EMA #daraxonrasib #Éire #fda #Health #IE #Inc #Ireland #Medication #NationalPriorityVoucher #PancreaticCancer #patients #PilotProgram #RASMutations #RevolutionMedicines
-
https://www.europesays.com/uk/1076256/ European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process #daraxonrasib #ema #FDA #Health #Inc #Medication #NationalPriorityVoucher #PancreaticCancer #patients #PilotProgram #RASMutations #RevolutionMedicines #UK #UnitedKingdom
-
https://www.europesays.com/at/261895/ Krebs-Blockbuster-Medikament: Revolution Medicines: Auch Europa will das Medikament so schnell wie möglich! | wallstreetONLINE #Bauchspeicheldrüsenkrebs #BiotechAktie #Daraxonrasib #EMA #EU #Europa #Europe #RevolutionMedicines
-
Krebs-Blockbuster-Medikament: Revolution Medicines: Auch Europa will das Medikament so schnell wie möglich! | wallstreetONLINE
Nach starken Studiendaten aus den USA will nach der FDA auch Europas Arzneimittelbehörde das Medikament so schnell wie…
#EuropeSays #EU #Europa #Bauchspeicheldrüsenkrebs #Biotech-Aktie #Daraxonrasib #EMA #RevolutionMedicines
https://www.europesays.com/europa/64516/ -
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
#Europe #EU #daraxonrasib #EMA #European #FDA #Inc. #NationalPriorityVoucher #pancreaticcancer #Patients #pilotprogram #RASmutations #RevolutionMedicines
https://www.europesays.com/europe/88500/ -
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
#Europe #EU #daraxonrasib #EMA #European #FDA #Inc. #NationalPriorityVoucher #pancreaticcancer #Patients #pilotprogram #RASmutations #RevolutionMedicines
https://www.europesays.com/europe/88482/ -
Pill almost doubles survival time for world’s deadliest cancer. A recent #AmericanSocietyOfClinicalOncology meeting in Chicago showed that #daraxonrasib, a daily pill, nearly doubled median survival for 500 people with previously treated metastatic #PancreaticCancer, from 6.7 to 13.2 months.
Daraxonrasib or Chemotherapy i... -
My comment at ForBetterScience.com👇
https://bit.ly/3RPS6wU
Venture capitalists funding rounds turn into main sources of funds for #BioTech startups
Some years ago, the US FDA adopted an "accelerated approval" pathway for therapies for serious diseases where approval depends on surrogate endpoints criteria, such as tumor shrinkage.
This is what we are seeing in the case of #Daraxonrasib and #Pancreatic #Cancer. -
My comment at ForBetterScience.com👇
https://bit.ly/3RPS6wU
Venture capitalists funding rounds turn into main sources of funds for #BioTech startups
Some years ago, the US FDA adopted an "accelerated approval" pathway for therapies for serious diseases where approval depends on surrogate endpoints criteria, such as tumor shrinkage.
This is what we are seeing in the case of #Daraxonrasib and #Pancreatic #Cancer. -
My comment at ForBetterScience.com👇
https://bit.ly/3RPS6wU
Venture capitalists funding rounds turn into main sources of funds for #BioTech startups
Some years ago, the US FDA adopted an "accelerated approval" pathway for therapies for serious diseases where approval depends on surrogate endpoints criteria, such as tumor shrinkage.
This is what we are seeing in the case of #Daraxonrasib and #Pancreatic #Cancer. -
Durchbruch bei #Bauchspeicheldrüsenkrebs: Die experimentelle Pille namens #Daraxonrasib verdoppelt die Überlebenszeit. #Krebs www.fr.de/wissen/ueber...
Durchbruch bei Bauchspeicheldr... -
“The company developing the drug, #RevolutionMedicines, presented results on May 31, 2026, from its Phase 3 clinical trial of 500 patients with metastatic #PancreaticCancer who had received prior treatment.
Compared to standard #chemotherapy, #daraxonrasib nearly doubled overall survival from 6.7 months to 13.2 months after diagnosis. Overall, daraxonrasib reduced the risk of death for metastatic pancreatic cancer patients by 60%.”https://www.sciencealert.com/a-breakthrough-drug-just-achieved-the-impossible-for-pancreatic-cancer
-
“The company developing the drug, #RevolutionMedicines, presented results on May 31, 2026, from its Phase 3 clinical trial of 500 patients with metastatic #PancreaticCancer who had received prior treatment.
Compared to standard #chemotherapy, #daraxonrasib nearly doubled overall survival from 6.7 months to 13.2 months after diagnosis. Overall, daraxonrasib reduced the risk of death for metastatic pancreatic cancer patients by 60%.”https://www.sciencealert.com/a-breakthrough-drug-just-achieved-the-impossible-for-pancreatic-cancer
-
“The company developing the drug, #RevolutionMedicines, presented results on May 31, 2026, from its Phase 3 clinical trial of 500 patients with metastatic #PancreaticCancer who had received prior treatment.
Compared to standard #chemotherapy, #daraxonrasib nearly doubled overall survival from 6.7 months to 13.2 months after diagnosis. Overall, daraxonrasib reduced the risk of death for metastatic pancreatic cancer patients by 60%.”https://www.sciencealert.com/a-breakthrough-drug-just-achieved-the-impossible-for-pancreatic-cancer
-
Sobrevida de pacientes com câncer metastático dobra com nova pílula; risco de morte caiu em 60%
https://fed.brid.gy/r/https://iclnoticias.com.br/sobrevida-cancer-metastatico-dobra-pilula/
-
Sobrevida de pacientes com câncer metastático dobra com nova pílula; risco de morte caiu em 60%
https://fed.brid.gy/r/https://iclnoticias.com.br/sobrevida-cancer-metastatico-dobra-pilula/
-
Sobrevida de pacientes com câncer metastático dobra com nova pílula; risco de morte caiu em 60%
https://fed.brid.gy/r/https://iclnoticias.com.br/sobrevida-cancer-metastatico-dobra-pilula/
-
PANCREATIC CANCER TREATMENT SEES UNPRECEDENTED PROGRESS WITH TARGETED DRUG
A new drug, daraxonrasib, targeting KRAS G12D mutation in pancreatic cancer, has nearly doubled median survival for advanced cases. Learn about the treatment.
#PancreaticCancer, #Daraxonrasib, #CancerTreatment, #KRASMutation, #MedicalBreakthrough
https://newsletter.tf/pancreatic-cancer-drug-daraxonrasib-doubles-survival/
-
Patients with advanced pancreatic cancer taking daraxonrasib lived a median of 13.2 months, almost double the 6.7 months with standard chemotherapy.
#PancreaticCancer, #Daraxonrasib, #CancerTreatment, #KRASMutation, #MedicalBreakthrough
https://newsletter.tf/pancreatic-cancer-drug-daraxonrasib-doubles-survival/ -
RE: https://flipboard.com/@ladbible/health-t1dkrhc7z/-/a-ZycNPyOkQ0WzpVWhq7wZ1w%3Aa%3A2318227232-%2F0
Under #Trump ’s “Most Favoured Nation” #price #policy, #cancer patients in the #EU may soon have to fly to the #US —and pay— for a #cure. The US still overpays; everyone else gets nothing, instead of globally negotiating a real minimum price. Another unwinnable war— after #iran this time on #health.
#pharma #healthcare #pancreas #daraxonrasib
#MFN #drugprices #standardofliving #LuigiMangione #Hormuz #profit #capitalism -
RE: https://flipboard.com/@ladbible/health-t1dkrhc7z/-/a-ZycNPyOkQ0WzpVWhq7wZ1w%3Aa%3A2318227232-%2F0
Under #Trump ’s “Most Favoured Nation” #price #policy, #cancer patients in the #EU may soon have to fly to the #US —and pay— for a #cure. The US still overpays; everyone else gets nothing, instead of globally negotiating a real minimum price. Another unwinnable war— after #iran this time on #health.
#pharma #healthcare #pancreas #daraxonrasib
#MFN #drugprices #standardofliving #LuigiMangione #Hormuz #profit #capitalism -
RE: https://flipboard.com/@ladbible/health-t1dkrhc7z/-/a-ZycNPyOkQ0WzpVWhq7wZ1w%3Aa%3A2318227232-%2F0
Under #Trump ’s “Most Favoured Nation” #price #policy, #cancer patients in the #EU may soon have to fly to the #US —and pay— for a #cure. The US still overpays; everyone else gets nothing, instead of globally negotiating a real minimum price. Another unwinnable war— after #iran this time on #health.
#pharma #healthcare #pancreas #daraxonrasib
#MFN #drugprices #standardofliving #LuigiMangione #Hormuz #profit #capitalism -
Daily pill can double survival time for world’s deadliest #cancer trial shows
Experts hail #daraxonrasib as ‘gamechanger’ for patients with advanced #pancreatic cancer -
Daily pill can double survival time for world’s deadliest #cancer trial shows
Experts hail #daraxonrasib as ‘gamechanger’ for patients with advanced #pancreatic cancer -
Revolution Medicines' pancreatic cancer therapy daraxonrasib has delivered stunning results in clinical trials, offering patients significantly more time to live and laying the groundwork for future advancements. https://www.japantimes.co.jp/commentary/2026/04/24/world/progress-against-pancreatic-cancer/?utm_medium=Social&utm_source=mastodon #commentary #worldnews #daraxonrasib #revolutionmedicine #pancreaticcancer #cancer #health #medicine #chemotherapy
-
Revolution Medicines' pancreatic cancer therapy daraxonrasib has delivered stunning results in clinical trials, offering patients significantly more time to live and laying the groundwork for future advancements. https://www.japantimes.co.jp/commentary/2026/04/24/world/progress-against-pancreatic-cancer/?utm_medium=Social&utm_source=mastodon #commentary #worldnews #daraxonrasib #revolutionmedicine #pancreaticcancer #cancer #health #medicine #chemotherapy
-
Revolution Medicines' pancreatic cancer therapy daraxonrasib has delivered stunning results in clinical trials, offering patients significantly more time to live and laying the groundwork for future advancements. https://www.japantimes.co.jp/commentary/2026/04/24/world/progress-against-pancreatic-cancer/?utm_medium=Social&utm_source=mastodon #commentary #worldnews #daraxonrasib #revolutionmedicine #pancreaticcancer #cancer #health #medicine #chemotherapy
